FDA Approves Four More Member States For US-EU Inspections MRA
Executive Summary
The landmark mutual recognition agreement is now operational between 12 EU member states and the US Food and Drug Administration.
You may also be interested in...
FDA Mulls Which EU Inspections To Skip Under EU MRA
As US FDA sets its FY 2018 inspection priorities, it is considering whether there are recent or upcoming inspections by inspectorates in eight European countries recognized under a US/EU mutual recognition agreement that it could rely on instead, agency official says. Over time, FDA could rely more on EU inspection priorities.
New EU Filings
Vutrisiran, Alnylam’s investigational RNAi therapeutic for treating hereditary transthyretin-mediated amyloidosis in adults with polyneuropathy, is among the latest new medicines that have been submitted for review for potential pan-EU approval.